Significant elevation of IGF2BP2 expression in patients with head and neck squamous cell carcinoma (HNSC) was observed, whereas its expression was decreased in some other cancers, such as breast cancer and renal clear cell carcinoma. Here, IGF2BP2 is linked to head and neck squamous cell carcinoma.